Cargando…
Mucosal effects of tenofovir 1% gel
Tenofovir gel is being evaluated for vaginal and rectal pre-exposure prophylaxis against HIV transmission. Because this is a new prevention strategy, we broadly assessed its effects on the mucosa. In MTN-007, a phase-1, randomized, double-blinded rectal microbicide trial, we used systems genomics/pr...
Autores principales: | Hladik, Florian, Burgener, Adam, Ballweber, Lamar, Gottardo, Raphael, Vojtech, Lucia, Fourati, Slim, Dai, James Y, Cameron, Mark J, Strobl, Johanna, Hughes, Sean M, Hoesley, Craig, Andrew, Philip, Johnson, Sherri, Piper, Jeanna, Friend, David R, Ball, T Blake, Cranston, Ross D, Mayer, Kenneth H, McElrath, M Juliana, McGowan, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391502/ https://www.ncbi.nlm.nih.gov/pubmed/25647729 http://dx.doi.org/10.7554/eLife.04525 |
Ejemplares similares
-
Correction: Mucosal effects for tenofovir 1% gel
por: Hladik, Florian, et al.
Publicado: (2015) -
A Phase 1 Randomized, Double Blind, Placebo Controlled Rectal Safety and Acceptability Study of Tenofovir 1% Gel (MTN-007)
por: Mcgowan, Ian, et al.
Publicado: (2013) -
Initial Events in Establishing Vaginal Entry and Infection by Human Immunodeficiency Virus Type-1
por: Hladik, Florian, et al.
Publicado: (2007) -
Rectal 1% Tenofovir Gel Use Associates with Altered Epidermal Protein Expression
por: Romas, Laura, et al.
Publicado: (2016) -
Exosomes in human semen carry a distinctive repertoire of small non-coding RNAs with potential regulatory functions
por: Vojtech, Lucia, et al.
Publicado: (2014)